Views & Analysis Five tech companies advancing against cancer New cancer tech devices for oncology screening, diagnosis and mental wellbeing.
News Kisqali set for approval - but likely to hit same NICE obsta... Concerns that NICE will reject Kisqali like it did Ibrance.
News Seattle, Takeda aim for first line Adcetris use Seattle CEO hopes Adcetris will be standard of care.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
R&D On genomics, NGS, and doing much more good than bad, with Ma... Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
